Literature DB >> 15013254

Interleukin-1beta and tumor necrosis factor-alpha in children with major depressive disorder or dysthymia.

F Brambilla1, P Monteleone, M Maj.   

Abstract

BACKGROUND: Immune function is altered in adult depressed patients. The aim of our study was to see whether or not cytokine secretion is impaired at a very young phase of development of depressive disorders, possibly being pathogenetically involved in their course.
METHODS: Basal plasma concentrations of interleukin-1beta (Il-1beta) and tumor necrosis factor-alpha (TNF-alpha) were measured radioimmunologically in 22 drug-free children-adolescents, 11 with recurrent major depressive disorders (MDD) and 11 with dysthymia (DYS), and in 11 psychophysically healthy age-sex matched controls. Depression was monitored using the Poznanski Rating Scale and Anxiety with the Reynold Rating Scale.
RESULTS: Il-1beta levels were not significantly different in MDD from controls and significantly higher than normal in DYS subjects. TNF-alpha levels were not significantly different in MDD patients from controls and significantly lower than normal in DYS patients. Cytokine concentrations were correlated with anxious and depressive symptomatology in MDD but not in DYS patients.
CONCLUSIONS: There is a cytokine pathology in depressive disorders of obscure etiopathogenetical significance.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15013254     DOI: 10.1016/S0165-0327(02)00315-4

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  29 in total

1.  Interleukin-1β: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis.

Authors:  Patricia A Zunszain; Christoph Anacker; Annamaria Cattaneo; Shanas Choudhury; Ksenia Musaelyan; Aye Mu Myint; Sandrine Thuret; Jack Price; Carmine M Pariante
Journal:  Neuropsychopharmacology       Date:  2011-11-09       Impact factor: 7.853

Review 2.  Adolescent-Onset Depression: Are Obesity and Inflammation Developmental Mechanisms or Outcomes?

Authors:  Michelle L Byrne; Neil M O'Brien-Simpson; Sarah A Mitchell; Nicholas B Allen
Journal:  Child Psychiatry Hum Dev       Date:  2015-12

3.  Immune system dysregulation in adolescent major depressive disorder.

Authors:  Vilma Gabbay; Rachel G Klein; Carmen M Alonso; James S Babb; Melissa Nishawala; Georgette De Jesus; Glenn S Hirsch; Pauline M Z Hottinger-Blanc; Charles J Gonzalez
Journal:  J Affect Disord       Date:  2008-09-13       Impact factor: 4.839

Review 4.  Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies.

Authors:  Jennifer M Loftis; Marilyn Huckans; Benjamin J Morasco
Journal:  Neurobiol Dis       Date:  2009-11-26       Impact factor: 5.996

Review 5.  Inflammatory cytokine-associated depression.

Authors:  Francis E Lotrich
Journal:  Brain Res       Date:  2014-07-05       Impact factor: 3.252

Review 6.  Environmental Exposures and Neuropsychiatric Disorders: What Role Does the Gut-Immune-Brain Axis Play?

Authors:  Shannon Delaney; Mady Hornig
Journal:  Curr Environ Health Rep       Date:  2018-03

7.  IL-1β, IL-6, IL-8, IL-10, IFN-γ, TNF-α and its relationship with lipid parameters in patients with major depression.

Authors:  Cicek Hocaoglu; Birgul Kural; Rezzan Aliyazıcıoglu; Orhan Deger; Sevil Cengiz
Journal:  Metab Brain Dis       Date:  2012-06-19       Impact factor: 3.584

Review 8.  Inflammatory biomarkers and depression.

Authors:  Norbert Müller; Aye-Mu Myint; Markus J Schwarz
Journal:  Neurotox Res       Date:  2010-07-24       Impact factor: 3.911

Review 9.  Glucocorticoid dysregulations and their clinical correlates. From receptors to therapeutics.

Authors:  Andrea H Marques; Marni N Silverman; Esther M Sternberg
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

10.  Inflammatory cytokines and nuclear factor-kappa B activation in adolescents with bipolar and major depressive disorders.

Authors:  David J Miklowitz; Larissa C Portnoff; Casey C Armstrong; Danielle Keenan-Miller; Elizabeth C Breen; Keely A Muscatell; Naomi I Eisenberger; Michael R Irwin
Journal:  Psychiatry Res       Date:  2016-05-07       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.